Health Condition 1: I501- Left ventricular failure, unspecified
Conditions
Interventions
None listed
Sponsors
National Institute of Ayurveda Jaipur
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult patients of both genders, with stable HF (NYHA classification up to Class III and reduced EF not more than 40% and not less than 15%. 2. Patients who have already taken conventional therapy for more than or equal to 3 months and yet have the above criteria would also be included.
Exclusion criteria
Exclusion criteria: 1.Patients with an Ejection Fraction of the Left Ventricle more than or equal to 40 percent and less than or equal to 15 percent will not be included in the study. 2.Patients with a history of Unstable Angina, Acute Myocardial infarction (newly diagnosed acute cases), valvular defects, congenital heart disease, pericarditis, arrhythmia, Pericardial effusion, uncontrolled Hypertension (more than or equal to 150/90 mm Hg) 3.Patients with a history of extra Cardiac ailments like renal failure, uncontrolled diabetes mellitus (HbA1c more than or equal to 8%) with or without complications, chronic alcoholics, and pregnant/lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change present in ejection fraction in 2D echocardiography of the heart after 2 months of trial.Timepoint: 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| • Changes in signs and symptoms of Kaphaja Hridroga after 2 months of trial. • Changes in symptoms using a standardized tool, the KCC Questionnaire after 2 months of trial. • Frequency and severity of adverse effects documented during the intervention after 2 months of trial.Timepoint: 2 months | — |
Countries
India
Contacts
Public ContactProf Udai Raj Saroj
National Institute of Ayurveda, Jaipur
Outcome results
None listed